Long-term results after external beam radiation therapy for T1-T2 localized prostate cancer.
The incidence of organ-confined and early-stage prostate cancer has increased. The external beam radiation therapy has proven to be a good therapeutic option in terms of biochemical survival and overall survival. It has been modified throughout the years; consequently, the available data on the long-term efficacy of external beam radiation therapy are difficult to compare with the commonly used improved radiation strategies. Intensity-modulated conformal radiotherapy and three-dimensional conformal radiotherapy result in better tumor control at a lower complication rate. External beam radiotherapy seems to be favored in intermediate- and high-risk groups for relapse of prostate cancer and radical prostatectomy is favored in the low-risk group. However, they score similarly in terms of general health-related quality of life after treatment.
Lagerveld
B W
BW
Department of Urology, Academic Medical Center, University of Amsterdam, Meibergdreef 9 (G4-105.1), 1105 AZ, Amsterdam Z-O, The Netherlands.
Laguna
M P
MP
de la Rosette
J J M C H
JJ
D006304:Health Status; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D017063:Outcome Assessment, Health Care; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology* / Q000532:radiotherapy*; D011788:Quality of Life; D015996:Survival Rate; D013997:Time Factors